Steven Narod

Steven Narod is affiliated with the Women 's College Research Institute.[1]He is a member of Familial Breast Cancer Research Unit.[2]

Dr. Steven Narod is a researcher at the Women's College Research Institute in Toronto.[3]He was part of the team that discovered the BRCA1 and BRCA2 mutations and he has contributed to the identification of genetic mutations in a number of ethnic populations, including people of French-Canadian, Bahamian and Ashkenazi Jewish descent.[4]In April, he received the Killam Prize for Health Sciences from the Canadian Council for the Arts.[5]Through both his research and vast clinical work, he became an early proponent of prophylactic surgeries as the most effective way to treat patients with BRCA mutations — which create higher risks for cancer in both the breasts and ovaries.[5]With more than 700 peer-reviewed publications, Dr. Narod is one of the most published and highly cited cancer researchers in the world.[6]In 2012, Dr. Narod was elected as a Fellow of the Royal Society of Canada.[6]

Events - Primer's event detection algorithm clusters and summarizes multiple documents describing real-world events.

Mentions - Mentions are snippets of text that map to a person.

Docs - The number of documents that match to a person in Primer's corpus of news articles.

Full tech explainer here.

Create an article for Steven Narod on Wikipedia

Remember to check the sources and follow Wikipedia's guidelines.

Women 's College Research Institute


  • 2


  • 340


  • 103


Recent events

'Stage 0' breast cancer surgically overtreated in U.S.

While doctors may argue about whether surgery is warranted in all cases of DCIS, a new study suggests that radiation after surgery does not increase survival for women with the condition. Breast cancer expert Dr. Steven Narod, lead author of the paper, says the findings put to rest the question of whether DCIS is cancer or pre-cancer. The study looked at over 100,000 women diagnosed with DCIS between 1988 and 2011 and assessed how many had died of breast cancer 10 and 20 years after the diagnosis. At 20 years, 3.3 per cent of the women had died of breast cancer.[789]


Event Date

Genetic counseling is rare among BRCA-tested women

Although counseling is widely recommended before gene testing, most U.S. women who were sent by doctors to be tested for BRCA1 and BRCA2, two genes that increase the risk of breast and ovarian cancer, never met with a counselor beforehand. Although women who received counseling before gene testing were more knowledgeable about the test and the meaning of its results, as well as more satisfied overall, some experts say traditional genetic counseling may no longer be the only or best option – especially as gene tests become cheaper and more accessible. The new study involved Aetna-insured women whose doctors ordered BRCA testing in 2012. In an editorial, Dr. Steven Narod of the Women's College Research Institute in Toronto writes that more women will likely be tested for BRCA mutations with the cost of genetic testing now ranging from US$200 to US$300.[101112]


Event Date